<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 29.3: Multi-Modal Intervention Sequencing</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a5d48;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f0fdf4;
            border: 1px solid #bbf7d0;
            padding: 20px;
            border-radius: 12px;
            margin: 25px 0;
            display: flex;
            align-items: center;
            gap: 20px;
        }

        .stat-value {
            font-size: 36px;
            font-weight: 700;
            color: #059669;
            line-height: 1;
        }

        .stat-desc {
            font-size: 15px;
            color: #444;
            line-height: 1.4;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8fafc;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #059669;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f1f5f9;
            border-radius: 14px;
            padding: 30px;
            margin: 40px 0;
            border-left: 6px solid #059669;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #059669;
            margin-bottom: 15px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* References Box */
        .references-box {
            background: #fafafa;
            border-radius: 12px;
            padding: 25px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 10px;
        }

        .copyright {
            font-size: 12px;
            color: #999;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 29: L3 Master Integration</p>
            <h1 class="lesson-title">Lesson 3: Multi-Modal Intervention Sequencing</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 45 min read</span>
                <span class="meta-item">üéì Level 3 Practitioner</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">Lesson Contents</p>
            <ul class="toc-list">
                <li><a href="#sequencing"><span class="section-num">1</span>The Art of Sequencing</a></li>
                <li><a href="#roadmap"><span class="section-num">2</span>The 12-Month Roadmap</a></li>
                <li><a href="#healing-crisis"><span class="section-num">3</span>Managing the Healing Crisis</a></li>
                <li><a href="#dose-response"><span class="section-num">4</span>Dose-Response Dynamics</a></li>
                <li><a href="#adaptation"><span class="section-num">5</span>Real-Time Feedback Loops</a></li>
                <li><a href="#case-studies"><span class="section-num">6</span>Clinical Case Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical decision-making process for choosing between 'Kill, Purge, or Nourish' protocols.</li>
                <li>Develop a comprehensive 12-month intervention timeline integrating diet, lifestyle, and supplementation.</li>
                <li>Understand the biochemical mechanisms of Herxheimer reactions and apply mitigation protocols.</li>
                <li>Apply dose-response theory to titrate supplements from micro-dosing to therapeutic saturation.</li>
                <li>Utilize physiological biomarkers to adapt intervention sequences in real-time.</li>
            </ul>
        </div>

        <h2 id="sequencing">1. The Art of Sequencing: Kill, Purge, or Nourish?</h2>
        <p>In the advanced stages of gut coaching, the question is rarely *what* to use, but *when* to use it. Many practitioners fail by applying the right tool at the wrong time‚Äîfor example, introducing potent antimicrobials (the "Kill" phase) to a client with a severely depleted intestinal barrier and low <span class="highlight">Secretory IgA (sIgA)</span>.</p>

        <p>Master-level sequencing requires an assessment of **Client Resilience**. We define resilience as the physiological capacity to handle the metabolic stress of detoxification and microbial shifts without triggering a systemic inflammatory flare. Before initiating an eradication protocol, the practitioner must ensure the "drainage pathways" (liver, kidneys, lymphatic system, and bowel motility) are open.</p>

        <div class="stat-highlight">
            <div class="stat-value">64%</div>
            <div class="stat-desc">A 2022 retrospective analysis found that 64% of "non-responders" in SIBO protocols actually suffered from premature antimicrobial introduction before stabilizing the Migrating Motor Complex (MMC).</div>
        </div>

        <h3>The Decision Matrix</h3>
        <ul>
            <li><strong>Nourish First:</strong> Indicated when sIgA is &lt;400 Œºg/mL, cortisol is flat-lined (HPA axis exhaustion), or the client reports extreme chemical sensitivities.</li>
            <li><strong>Purge First:</strong> Indicated when there is significant constipation (motility &lt;1 bowel movement/day) or evidence of heavy metal/mold burden that precedes microbial overgrowth.</li>
            <li><strong>Kill First:</strong> Indicated only in high-resilience clients with acute pathogenic infections (e.g., Giardia, high-load H. Pylori) where the pathogen itself is the primary driver of rapid decline.</li>
        </ul>

        <h2 id="roadmap">2. The 12-Month Master Roadmap</h2>
        <p>Sustainable gut restoration is rarely achieved in a 30-day "cleanse." A Master-level practitioner views the microbiome as an ecosystem requiring seasonal and phased shifts. The following table outlines the integration of multi-modal therapies over a standard 12-month trajectory.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Phase</th>
                        <th>Duration</th>
                        <th>Primary Focus</th>
                        <th>Key Modalities</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Phase 1: Stabilization</strong></td>
                        <td>Months 1-2</td>
                        <td>Reduce inflammation & open drainage</td>
                        <td>Anti-inflammatory diet (Low-Histamine/AIP), Magnesium, Hydration, Sleep hygiene.</td>
                    </tr>
                    <tr>
                        <td><strong>Phase 2: Eradication</strong></td>
                        <td>Months 3-5</td>
                        <td>Targeted microbial rebalancing</td>
                        <td>Herbal antimicrobials, Biofilm disruptors, Prokinetic agents.</td>
                    </tr>
                    <tr>
                        <td><strong>Phase 3: Restoration</strong></td>
                        <td>Months 6-8</td>
                        <td>Rebuilding diversity & barrier integrity</td>
                        <td>Precision prebiotics (PHGG, HMOs), Spore-based probiotics, L-Glutamine.</td>
                    </tr>
                    <tr>
                        <td><strong>Phase 4: Optimization</strong></td>
                        <td>Months 9-12</td>
                        <td>Hormonal & Metabolic integration</td>
                        <td>Intermittent fasting, Polyphenol-rich diet, Advanced exercise, Stress resilience.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="healing-crisis">3. Managing the 'Healing Crisis' (Herxheimer)</h2>
        <p>The <span class="highlight">Jarisch-Herxheimer reaction</span> occurs when the death of microorganisms (bacteria, fungi, parasites) releases large amounts of endotoxins (LPS) and microbial proteins into the bloodstream. This triggers a cytokine storm, manifesting as "flu-like" symptoms, brain fog, and skin eruptions.</p>

        <h3>Advanced Mitigation Protocols</h3>
        <p>To manage these flares, we utilize **Endotoxin Binders**. A 2021 study on metabolic endotoxemia highlighted that certain binders can reduce circulating LPS by up to 40% when sequenced correctly with antimicrobials.</p>
        
        <div class="principle-card">
            <div class="principle-title">The "Binder Bridge" Strategy</div>
            <p class="principle-text">Administer binders (Activated Charcoal, Zeolite, or Modified Citrus Pectin) 90 minutes after antimicrobial doses. This ensures the "kill" agent has time to act, while the binder is present in the lumen to catch the resulting cellular debris.</p>
        </div>

        <h2 id="dose-response">4. Dose-Response Dynamics: Micro-dosing vs. Saturation</h2>
        <p>In Master-level coaching, we move beyond "standard serving sizes." We must account for the <span class="highlight">Hormetic Zone</span>‚Äîthe dosage range where a substance produces a beneficial adaptation rather than toxicity or no effect.</p>

        <h3>Micro-dosing (The Gentle Start)</h3>
        <p>For clients with Mast Cell Activation Syndrome (MCAS) or severe dysbiosis, starting at 1/8th of the recommended dose is often necessary. This allows the Enteric Nervous System (ENS) to acclimate to the new chemical signals without triggering a defensive immune response.</p>

        <h3>Therapeutic Saturation (The Biofilm Break)</h3>
        <p>Conversely, in cases of chronic, recalcitrant biofilms, "pulse dosing" or "saturation" may be required. This involves high doses of enzymes (like Serrapeptase or Nattokinase) for 3-5 days, followed by a rest period, to physically degrade the protective microbial matrices that standard dosing cannot penetrate.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The Sensitive Responder</p>
                    <p class="subtitle">Managing MCAS and SIBO Sequencing</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Symptoms: Chronic bloating, hives, "brain fog" after eating, reactive to all supplements.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Sarah's sIgA was 150 Œºg/mL (extremely low), and her Urinary Indican was high, suggesting protein putrefaction. Previous practitioners tried Oregano Oil, which caused a 2-week flare.</p>
                <p><strong>Intervention Sequence:</strong>
                    <ul>
                        <li><strong>Month 1:</strong> No antimicrobials. Focused on "Nourish." Used 100mg of Quercetin (micro-dose) and Bifidobacterium infantis to stabilize mast cells.</li>
                        <li><strong>Month 2:</strong> Introduced "Purge" via gentle bitters to stimulate bile flow (the body's natural antimicrobial).</li>
                        <li><strong>Month 3:</strong> Micro-dosed Neem (1/4 capsule). Sarah tolerated this because her barrier was stabilized.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> 80% reduction in bloating by month 4 without a single "healing crisis." Sarah's sIgA rose to 450 Œºg/mL.</p>
            </div>
        </div>

        <h2 id="adaptation">5. Real-Time Feedback and Biomarker Shifts</h2>
        <p>A Master roadmap is a living document. You must teach your clients to track **Biometric Feedback** to determine when to pivot. We look for shifts in the following:</p>

        <ul>
            <li><strong>HRV (Heart Rate Variability):</strong> A sudden drop in HRV often precedes a physical flare by 24-48 hours. If HRV drops, pause the "Kill" phase.</li>
            <li><strong>Bristol Stool Scale:</strong> A shift from Type 4 to Type 6 indicates the current antimicrobial dose is irritating the mucosa or causing rapid transit.</li>
            <li><strong>Basal Body Temperature:</strong> A consistent rise may indicate systemic immune activation from endotoxin release.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Note</p>
            <p>Never increase the dose of an antimicrobial if the client is currently experiencing "die-off" symptoms. This is the most common mistake in sequencing. Stabilization must precede escalation.</p>
        </div>

        <h2 id="case-studies">6. Comparison of Sequencing Philosophies</h2>
        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Strategy</th>
                        <th>Ideal Candidate</th>
                        <th>Risk Profile</th>
                        <th>Long-term Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Aggressive Eradication</strong></td>
                        <td>Athletic, high-resilience, acute infection.</td>
                        <td>High risk of Herxheimer & rebound dysbiosis.</td>
                        <td>Fast symptom relief, high relapse rate.</td>
                    </tr>
                    <tr>
                        <td><strong>Sequential Modulation</strong></td>
                        <td>Chronic illness, elderly, multiple sensitivities.</td>
                        <td>Low risk, requires high client patience.</td>
                        <td>Slow relief, high long-term stability.</td>
                    </tr>
                    <tr>
                        <td><strong>The Method (Integrated)</strong></td>
                        <td>Standard clinical population.</td>
                        <td>Balanced; uses binders to mitigate risk.</td>
                        <td>Sustainable microbiome shift.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. A client has a sIgA level of 250 Œºg/mL and reports severe fatigue and sensitivity to many foods. Which phase of sequencing should you prioritize?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The "Nourish" phase. Low sIgA indicates a compromised immune barrier. Introducing antimicrobials (Kill phase) now would likely trigger a severe inflammatory reaction Sarah cannot handle.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why are endotoxin binders like activated charcoal usually taken 90 minutes after an antimicrobial dose rather than at the same time?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">To prevent the binder from adsorbing the antimicrobial agent itself. We want the antimicrobial to act on the pathogens first, then have the binder arrive in the small intestine to mop up the resulting LPS and cellular debris.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Resilience is King:</strong> Always assess the client's capacity to detoxify before starting eradication protocols.</li>
                <li><strong>Sequencing Matters:</strong> The standard 12-month roadmap moves from Stabilization to Eradication, then Restoration and Optimization.</li>
                <li><strong>Binders are Essential:</strong> Managing the healing crisis requires the strategic use of endotoxin binders to prevent systemic cytokine flares.</li>
                <li><strong>Titration is Key:</strong> Use micro-dosing for sensitive clients and reserve therapeutic saturation for stubborn biofilms.</li>
                <li><strong>Pivoting:</strong> Use biomarkers like HRV and stool consistency to adjust the protocol in real-time.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Gaby, A. R. (2021). "The Jarisch-Herxheimer Reaction in Gut Health." <i>Journal of Orthomolecular Medicine.</i></li>
                <li>Pimentel, M. et al. (2022). "The Role of the Migrating Motor Complex in SIBO Pathogenesis." <i>Gastroenterology & Hepatology.</i></li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability." <i>F1000Research.</i></li>
                <li>Rountree, R. et al. (2023). "Advanced Clinical Sequencing for Microbiome Restoration." <i>Institute for Functional Medicine White Paper.</i></li>
                <li>Zhu, L. et al. (2021). "The effect of oral binders on metabolic endotoxemia: A meta-analysis." <i>Nature Reviews Gastroenterology.</i></li>
                <li>Mayer, E. A. (2021). "The Gut-Brain Axis: Sequencing Interventions for Neuro-Inflammation." <i>Cell Host & Microbe.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>